Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Remony is a longevity-focused health technology company that leverages systems biology and multi-omic data to optimize human healthspan. Founded by Dr. Nathan Price and Dr. Lee Hood, pioneers in personalized medicine and systems biology, the company provides a platform for biological age testing and personalized health interventions. The Remony platform integrates longitudinal data from blood biomarkers, genetics, and lifestyle factors to generate actionable insights aimed at slowing the biological aging process. By transitioning from reactive sick-care to proactive scientific wellness, Remony seeks to empower individuals with precise, data-driven strategies for extending their healthy years.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on REMONY.